Clinical Trial Update: A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the efficacy of NIO752 in participants with Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS); the study status is NOT_Y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Supranuclear Palsy

Drugs mentioned

• NIO752

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS) | Phase 3 | Status: NOT_YET_RECRUITING